USA Sermorelin Clinic :: Page 34

Reading Time: 3 minutesIntroduction As the American male population ages, the maintenance of bone health becomes increasingly critical. Osteoporosis and osteopenia, conditions characterized by reduced bone density, are prevalent among older men and can lead to increased fracture risk and diminished quality of life. Recent advancements in testosterone replacement therapy offer potential benefits for bone health. This article delves into a three-year longitudinal study exploring the effects of Tlando oral capsules, a novel testosterone replacement therapy, on bone density in American males over the age of 50. Study Design and Methodology The study involved 250 American males aged 50 and above, all diagnosed … Continue reading →

Reading Time: 2 minutesIntroduction The landscape of testosterone replacement therapy (TRT) has evolved significantly over the past decade, with oral formulations like Tlando gaining prominence. Tlando, an oral testosterone undecanoate capsule, offers a novel approach to managing hypogonadism. This article delves into a comprehensive 10-year follow-up study examining the impact of Tlando on prostate health among American males, providing critical insights into its long-term safety and efficacy. Study Design and Methodology The study followed a cohort of 500 American males aged 40 to 70 years diagnosed with hypogonadism and prescribed Tlando. Participants underwent regular monitoring, including prostate-specific antigen (PSA) tests, digital rectal examinations … Continue reading →